Chronic ill-health and the chances of surviving a heart attack
New research has identified the devastating impact of pre-existing health problems on recovery from a heart attack.
Mar 6, 2018
0
42
New research has identified the devastating impact of pre-existing health problems on recovery from a heart attack.
Mar 6, 2018
0
42
Cells that line the interior surface of blood vessels (endothelial cells) have the capacity to clonally expand and contribute to the development of new vessels due to inadequate blood supply to the heart, known as ischemia, ...
Jan 22, 2018
0
2
(HealthDay)—The odds of carotid artery stenting (CAS) have increased in the post-Carotid Revascularization Endarterectomy vs Stenting Trial (CREST) era, despite safety concerns for patients older than 70 years, according ...
Dec 4, 2017
0
1
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) identifies a signaling pathway that is essential for angiogenesis, the growth of new blood vessels from pre-existing vessels. The ...
Nov 23, 2017
0
1648
The public should be consulted before gene editing is used to treat human embryos, according to a survey of scientists published in the American Heart Association's journal Circulation: Cardiovascular Genetics.
Oct 3, 2017
0
1
Sometimes perfecting an existing technique can open the doors to new possibilities.
Sep 26, 2017
0
2
Clinicians are being warned not to ignore the increased cardiovascular health risks of those who are classed as either 'healthy obese' or deemed to be 'normal weight' but have metabolic abnormalities such as diabetes.
Sep 11, 2017
0
8
A recent paper published in Age & Ageing, the scientific journal of the British Geriatrics Society, finds that current smoking in older people increases the risk of developing frailty, though former smokers did not appear ...
Aug 17, 2017
0
2
For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida Health researcher has found that aspirin may provide little or no benefit for certain patients ...
Jun 5, 2017
0
191
(HealthDay)—The type 2 diabetes prescription drug canagliflozin (brand names Invokana, Invokamet, Invokamet XR) appears to increase the risk of leg and foot amputations, the U.S. Food and Drug Administration says.
May 17, 2017
0
0